Trial Profile
Effect of Vorapaxar Pharmacodynamics on Thrombogenicity, Endothelial Function, and Interactions with Clopidogrel and Aspirin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Aug 2019
Price :
$35
*
At a glance
- Drugs Vorapaxar (Primary) ; Aspirin; Clopidogrel
- Indications Arterial thrombosis; Cardiovascular disorders
- Focus Pharmacodynamics
- 24 Aug 2019 Results evaluating the comparative effects of vorapaxar on platelet fibrin clot characteristics, coagulation, inflammation, and platelet and endothelial function published in the Journal of Thrombosis and Haemostasis
- 07 May 2018 New trial record
- 12 Mar 2018 Results presented at the 67th Annual Scientific Session of the American College of Cardiology